76.5EGP
- Active ingredient
- zolmitriptan
- Strength
- 5 mg
- Form
- tablet
- Manufacturer
- global napi pharmaceuticals
- Route
- oral.solid
Uses
Used for the acute treatment of migraine attacks with or without aura in adults. Not intended for migraine prevention.
Do not use if
Contraindicated in ischemic heart disease, coronary vasospasm, certain arrhythmias, stroke history, and uncontrolled hypertension.
Side effects
Dizziness, paresthesia, fatigue, chest or throat tightness, and somnolence may occur.
Warnings
Evaluate cardiovascular risk before use in susceptible patients. Discontinue if serious cardiac symptoms occur.
How it works
Selective 5-HT1B/1D receptor agonist that reduces migraine symptoms through cranial vasoconstriction and neuropeptide modulation.
Storage
Store at room temperature in the original package.